A new version of ResearchHub is available.Try it now
Paper
0
A Novel Generation of Anti-CD7 Universal CAR-T Therapy for Patients with Relapsed or Refractory CD7 Positive T-ALL/Lbl: A Phase I Clinical Trial
Authors
Journal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave